Level D· Scientific groundwork from lab and animal studiesNarrative ReviewEurope PMCOpen access

Fucoidan and alginate from brown seaweeds: extraction, structural diversity, biocompatibility, biodegradability, and biomedical applications

El-Sheekh MM., Alkafaas SS., Bases E., Zhu F., Yan X., Yousuf WE.

Narrative Review on Chronic Wound, published in Front Plant Sci (2026) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Narrative Review
Journal
Front Plant Sci (2026)
Reported sample size
—
Source database
Europe PMC
PMID
42359398
PMCID
PMC13290809
DOI
10.3389/fpls.2026.1845395

Abstract (original English)

Brown seaweeds are among the richest marine sources of structurally diverse polysaccharides, especially fucoidan and alginate, which have attracted significant attention as multifunctional biomaterials for pharmaceutical, biomedical, and regenerative medicine applications. This review provides a comprehensive overview of extraction and purification methods, including conventional chemical, enzymatic, microwave-assisted, and ultrasound-assisted techniques, discussing how these methods affect yield, purity, molecular weight distribution, sulfation patterns, and structural integrity. An in-depth examination of the chemical structure of fucoidan and alginate highlights the importance of monosaccharide composition, sulfation degree, M/G ratio, molecular weight, and block arrangement in influencing bioactivity, gelation, biodegradability, and interactions with biological systems. The review thoroughly evaluates biocompatibility and biodegradation mechanisms, focusing on the roles of impurities, crosslinking density, oxidation levels, enzymatic degradation pathways, and environmental factors. It also summarizes recent advances in fucoidan- and alginate-based formulations, including hydrogels, nanoparticles, films, nanofibers, microspheres, sponges, injectable gels, and composite scaffolds, as well as key drug delivery mechanisms like ionotropic gelation, diffusion-controlled release,

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is a narrative review: it collects no new patient data and does not systematically appraise evidence quality.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research